{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thyroid-gland-mixed-medullary-and-follicular-cell-derived-carcinoma","columns":[{"gene":"","key":"population-38fd31c345c5f00245cc","label":"thyroid gland mixed medullary and follicular cell-derived carcinoma","mondoId":"MONDO:0971035","onsetQualifier":null,"originColumnKey":"MONDO:0971035/no-native-evidence","originalViews":[{"key":"MONDO:0971035/no-native-evidence","label":"thyroid gland mixed medullary and follicular cell-derived carcinoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-38fd31c345c5f00245cc"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-38fd31c345c5f00245cc"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A thyroid gland carcinoma containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and follicular cell-derived carcinoma component that is immunohistochemically positive for thyroglobulin.","mondoId":"MONDO:0971035","node":{"canonicalSlug":"thyroid-gland-mixed-medullary-and-follicular-cell-derived-carcinoma","comparisons":[{"documentSha256":"866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1","key":"expanded-thyroid-tumor","kind":"expanded","label":"thyroid tumor","memberIds":["MONDO:0002821","MONDO:0003027","MONDO:0003028","MONDO:0003701","MONDO:0003806","MONDO:0003836","MONDO:0003837","MONDO:0004101","MONDO:0004102","MONDO:0004103","MONDO:0004460","MONDO:0004483","MONDO:0004524","MONDO:0004558","MONDO:0005032","MONDO:0005034","MONDO:0005075","MONDO:0006107","MONDO:0006462","MONDO:0006463","MONDO:0006466","MONDO:0006467","MONDO:0006468","MONDO:0006886","MONDO:0007958","MONDO:0008082","MONDO:0008234","MONDO:0008565","MONDO:0008566","MONDO:0008567","MONDO:0011312","MONDO:0011368","MONDO:0011578","MONDO:0011653","MONDO:0011836","MONDO:0014681","MONDO:0014682","MONDO:0015074","MONDO:0015075","MONDO:0015277","MONDO:0015447","MONDO:0017895","MONDO:0017896","MONDO:0019003","MONDO:0019611","MONDO:0019962","MONDO:0024622","MONDO:0971033","MONDO:0971034","MONDO:0971035","MONDO:0971036"],"mondoId":"MONDO:0015074","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-866dec3b944e19fd9ee6.866dec3b944e19fd9ee6f5f7499ee18495fe9c6bd2db4ec84e445cb237d228e1.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"thyroid gland mixed medullary and follicular cell-derived carcinoma","paragraphs":["A thyroid gland carcinoma containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and follicular cell-derived carcinoma component that is immunohistochemically positive for thyroglobulin."],"scope":"exact","source":"MONDO","upstream":"DOID:0081459","url":"https://monarchinitiative.org/MONDO:0971035"},"ownColumnKeys":["population-38fd31c345c5f00245cc"],"publication":"published","relationships":[{"kind":"parent","label":"thyroid gland carcinoma","mondoId":"MONDO:0015075","slug":"thyroid-gland-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/27157"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0971035\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0081459</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A thyroid gland carcinoma containing a medullary carcinoma component that is immunohistochemically positive for calcitonin, and follicular cell-derived carcinoma component that is immunohistochemically positive for thyroglobulin.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0971035\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"thyroid-gland-mixed-medullary-and-follicular-cell-derived-carcinoma","sourceDocuments":[{"name":"MONDO: thyroid gland mixed medullary and follicular cell-derived carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0971035"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"thyroid gland mixed medullary and follicular cell-derived carcinoma"},"schemaVersion":1}
